Anthera Pharmaceuticals Inc. buy Maxi_Scalibusa
Start price
23.02.18
/
50%
€2.16
Target price
15.03.18
€3.61
Performance (%)
-81.38%
End price
15.03.18
€0.40
Summary
This prediction ended on 15.03.18 with a price of €0.40. The BUY prediction by Maxi_Scalibusa for Anthera Pharmaceuticals Inc. performed very badly with a performance of -81.38%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Anthera Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | -5.630% | -5.765% | 8.425% | 8.571% |
iShares Nasdaq 100 | -8.559% | -13.005% | 17.297% | 28.853% |
iShares Nikkei 225® | -9.576% | -9.058% | 3.827% | 0.117% |
iShares S&P 500 | -6.631% | -7.103% | 17.407% | 31.169% |
Comments by Maxi_Scalibusa for this prediction
In the thread Anthera Pharmaceuticals Inc. diskutieren
Maxi-Scalibusa stimmt der Buy-Einschätzung von stratec zu
Maxi-Scalibusa stimmt am 22.02.2018 der Buy-Einschätzung von stratec mit dem Kursziel 4$ zu.
Überschrift: Anthera Pharmaceuticals initiated with Buy rating and $10 (492% upside) price target at ROTH Capital.
(Vom Mitglied beendet)